Valuation: ResMed, Inc.

Market Cap 29.04B 25.5B 23.47B 21.87B 41.25B 2,761B 42.09B 282B 109B 1,355B 109B 107B 4,717B P/E 2026 *
19x
P/E 2027 * 17.2x
Enterprise Value 28.27B 24.82B 22.85B 21.29B 40.16B 2,688B 40.97B 275B 106B 1,319B 106B 104B 4,592B EV / Sales 2026 *
5x
EV / Sales 2027 * 4.53x
Free-Float
75.61%
Yield 2026 *
1.21%
Yield 2027 * 1.34%
1 day+3.96%
1 week+1.73%
Current month+3.71%
1 month+12.62%
3 months-6.55%
6 months-13.56%
Current year-14.07%
1 week 168.75
Extreme 168.75
178.4
1 month 155.7
Extreme 155.7
178.4
Current year 155.7
Extreme 155.7
236.3
1 year 155.7
Extreme 155.7
250.2
3 years 126.4
Extreme 126.4
250.2
5 years 126.4
Extreme 126.4
255.5
10 years 50.46
Extreme 50.463
255.5
Manager TitleAgeSince
Chief Executive Officer 53 01/03/2013
Director of Finance/CFO 40 04/05/2026
Compliance Officer - 01/01/2018
Director TitleAgeSince
Director/Board Member 78 01/01/2005
Chairman 53 25/01/2023
Chairman 83 01/06/1989
Change 5-day change 1-year change 3-year change Capi.($)
+3.95%+1.73% - - 29.04B
+2.28%+3.51%+22.39%+0.85% 191B
+4.19%+3.70%-23.33%+23.35% 143B
+1.68%+1.42%-3.23%-17.25% 137B
+3.53%+0.14%-57.29%-17.33% 64B
+1.16%+3.72%+20.83%+1.72% 52.97B
+1.29%+1.25%-26.55%-31.27% 43.82B
-0.06%-1.87%+10.21%+11.45% 37.67B
-0.43%-0.32%+6.75%+41.89% 37.13B
+1.19%+0.60%-14.17%-19.04% 29.5B
Average +1.87%+2.37%-7.16%-0.63% 81.72B
Weighted average by Cap. +2.24%+3.37%-4.09%+0.22%

Financials

2026 *2027 *
Net sales 5.65B 4.96B 4.57B 4.26B 8.03B 537B 8.19B 54.92B 21.28B 264B 21.22B 20.76B 918B 6.09B 5.35B 4.92B 4.59B 8.65B 579B 8.83B 59.24B 22.95B 284B 22.88B 22.39B 990B
Net income 1.55B 1.36B 1.25B 1.17B 2.2B 147B 2.24B 15.05B 5.83B 72.23B 5.81B 5.69B 251B 1.7B 1.49B 1.37B 1.28B 2.41B 161B 2.46B 16.49B 6.39B 79.15B 6.37B 6.23B 275B
Net Debt -769M -676M -622M -579M -1.09B -73.15B -1.12B -7.48B -2.9B -35.91B -2.89B -2.83B -125B -1.43B -1.26B -1.16B -1.08B -2.03B -136B -2.08B -13.92B -5.39B -66.84B -5.38B -5.26B -233B
Logo ResMed, Inc.
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows: - medical devices (51.8%); - masks (35.7%); - software as a service (12.5%): residential care management software solutions. At the end of June 2025, the group had 8 production sites located in the United States (3), Australia, China, Singapore, Malaysia and France. The United States accounts for 63.8% of net sales.
Employees
10,600
Date Price Change Volume
02/07/26 176.25 +1.53% 0
01/07/26 €173.60 +2.15% 0
30/06/26 €169.95 -2.66% 0
29/06/26 €174.60 +0.90% 30
26/06/26 €173.05 -0.12% 0
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
201.10USD
Average target price
260.60USD
Spread / Average Target
+29.59%

Quarterly revenue - Rate of surprise